The findings that MZ1 and MRT-92 combination completely abrogates GLI1 expression and that ectopic expression of GLI1 is able to rescue the inhibition of melanoma cell growth induced by the drug combination, suggest that GLI1 is the main molecular and functional target of the SOX2-BRD4 transcriptional complex. Here, BRD4 is linked to melanoma.